Within contemporary peptide research, combinations of signal-modulating molecules are increasingly conceptualized as coordinated frameworks rather than isolated agents. Among these, the pairing of CJC-1295, a growth hormone–releasing hormone (GHRH) analog, with Ipamorelin, a ghrelin receptor–selective secretagogue, has drawn sustained theoretical interest. Research indicates that this blend may offer a unique window into pulsatile endocrine signaling,
Read More
https://www.youtube.com/watch?v=hiEVMblYRrw Michael Gwarisa In a major step toward improving the quality of cardiac care and reducing turnaround times for open heart surgeries in Zimbabwe, Parirenyatwa Group of Hospitals has commissioned a new heart bypass machine, also known as a heart lung machine. The brand new Stöckert S5 heart lung machine was procured by the
Read More
Kuda Pembere Zimbabwe has become the first African country to roll out a parenting mobile application designed as a one-stop digital resource offering reliable, expert advice on child health, safety and development to families nationwide. The Ministry of Health and Child Care, in partnership with UNICEF and with support from the Embassy of Japan in
Read More
Michael Gwarisa Though it has become a popular fashion statement, especially among modern women, performers, and artists, new research shows that dyeing hair in unnatural shades could be a silent cry for help and a sign of underlying mental health struggles. The full study Blue Hair and the Blues: Dying Your Hair Unnatural Colours is
Read More
On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin)Trusted Source for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Addyi was previously approved in 2015 for the treatment of HSDD in premenopausal women. Premenopause or “before” menopause refers to the reproductive time in a cisgender woman’s life when they have regular menstrual cycles.
Read More
By Michael Gwarisa Two young Zimbabweans have embarked on a mission to transform the nation’s healthcare landscape with a new digital tool, the Epi App. The innovation aims to provide real-time monitoring for epilepsy patients, potentially reducing the life-altering risks associated with the disorder. The mobile application, developed by Munashe Dube, a Bioengineering student at the
Read More
By Michael Gwarisa Zimbabwe continues to lose over 1,000 women to cervical cancer annually, with data showing that an estimated 3,043 women are diagnosed with the disease each year. Despite this grim reality, access to screening services for women in Zimbabwe remains a challenge due to a myriad of factors, including lack of knowledge and awareness,
Read More
By Staff Reporter THE country’s top provider of diagnostic and medical laboratory services, Cimas Medlabs has added the advanced genetic testing service on its procedures marking a significant milestone in the provision of cutting-edge healthcare solutions in Zimbabwe. As one of the leading medical laboratories in the country, Cimas Medlabs provides a wide range of pathology
Read More
While some patients experience adverse drug reactions (ADRs) when taking medicines, others do not, and in some cases, others do not receive therapeutic benefits from treatment regardless of dosage. One reason for this inter-individual variation in response is differences in genes that code for proteins important in drug response. This has given rise to the field
Read More